1,078.00
-1.2(-0.11%)
Currency In INR
Address
# 8-2-334, SDE Serene Chambers
Hyderabad, 500034
India
Phone
91 40 2354 9414
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1193
First IPO Date
March 09, 2020
| Name | Title | Pay | Year Born |
| Dr. Sudhir Kumar Singh Ph.D. | Chief Executive Officer | 0 | 1965 |
| Mr. Sunder Venkatraman | Vice President of Corporate Affairs | 0 | N/A |
| Mr. Vivek Sharma CPA | Executive Chairman | 0 | N/A |
| Dr. K. Nagendra Babu Ph.D. | Chief Quality & Compliance Officer | 0 | N/A |
| Mr. Himanshu Agarwal | Chief Financial Officer | 0 | 1970 |
| Ms. Cyndrella Carvalho | Head of Investor Relations | 0 | N/A |
| Mr. Gaurav Narain Bahadur | Chief Human Resources Officer | 0 | 1970 |
| Dr. Declan Ryan Ph.D. | Chief Commercial Officer | 0 | N/A |
| Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju Ph.D. | MD & Director | 0 | N/A |
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.